Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
 Back to Profile

Kimberly Jordan

Concepts (299)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Ovarian Neoplasms
7
2024
576
1.260
 Why?
Tumor Microenvironment
11
2024
668
1.260
 Why?
T-Lymphocytes
11
2022
1983
1.150
 Why?
Cancer Vaccines
7
2021
165
1.150
 Why?
Myeloid-Derived Suppressor Cells
5
2023
67
1.090
 Why?
Antigens, Neoplasm
6
2021
317
0.710
 Why?
Focal Adhesion Protein-Tyrosine Kinases
1
2020
35
0.680
 Why?
Receptors, Antigen, T-Cell
7
2021
718
0.670
 Why?
Cytoreduction Surgical Procedures
1
2020
61
0.650
 Why?
Antineoplastic Combined Chemotherapy Protocols
5
2024
1702
0.650
 Why?
Baculoviridae
3
2009
44
0.650
 Why?
Chemotherapy, Adjuvant
1
2020
373
0.610
 Why?
Image Processing, Computer-Assisted
1
2023
748
0.610
 Why?
Neoadjuvant Therapy
2
2022
407
0.590
 Why?
Insecta
3
2009
70
0.580
 Why?
Extracellular Vesicles
1
2020
147
0.580
 Why?
Granulocytes
1
2017
85
0.520
 Why?
Melanoma
4
2023
763
0.520
 Why?
Pancreatic Cyst
1
2017
48
0.500
 Why?
Lymphocyte Activation
4
2017
1146
0.490
 Why?
Monocytes
2
2020
563
0.450
 Why?
Spleen
1
2017
521
0.450
 Why?
CD8-Positive T-Lymphocytes
7
2024
912
0.440
 Why?
Vaccines
2
2010
402
0.440
 Why?
Programmed Cell Death 1 Receptor
3
2022
253
0.430
 Why?
Neoplasms
6
2017
2712
0.420
 Why?
Myeloid Cells
2
2020
150
0.410
 Why?
Vaccines, Subunit
2
2012
50
0.410
 Why?
Tomography, X-Ray Computed
1
2023
2693
0.400
 Why?
Colorectal Neoplasms
3
2024
817
0.400
 Why?
Histone-Lysine N-Methyltransferase
2
2024
134
0.390
 Why?
Complementarity Determining Regions
1
2012
51
0.370
 Why?
Xenograft Model Antitumor Assays
6
2024
865
0.340
 Why?
Benzimidazoles
2
2024
175
0.340
 Why?
Gamma Rays
2
2021
55
0.340
 Why?
Cell Line, Tumor
9
2024
3404
0.330
 Why?
Antineoplastic Agents, Immunological
4
2020
190
0.320
 Why?
Inflammation
1
2020
2847
0.310
 Why?
Mice
21
2024
17769
0.290
 Why?
Breast Neoplasms
1
2020
2274
0.280
 Why?
Immunotherapy
5
2021
631
0.280
 Why?
Pancreatic Neoplasms
3
2021
851
0.280
 Why?
Mice, Inbred BALB C
8
2021
1260
0.280
 Why?
H-2 Antigens
1
2008
115
0.280
 Why?
Antigens
1
2009
356
0.270
 Why?
Carcinoma, Pancreatic Ductal
2
2021
265
0.270
 Why?
Cell Proliferation
7
2024
2472
0.260
 Why?
Proteome
2
2022
471
0.260
 Why?
Tumor Escape
2
2017
43
0.260
 Why?
Antibodies, Monoclonal, Humanized
2
2024
815
0.260
 Why?
Peptide Library
4
2013
95
0.250
 Why?
Peptides
4
2021
980
0.250
 Why?
Survival Analysis
4
2021
1292
0.250
 Why?
Female
28
2025
73648
0.250
 Why?
Poly(ADP-ribose) Polymerase Inhibitors
2
2024
117
0.240
 Why?
Vaccination
3
2010
1431
0.240
 Why?
Transcriptome
2
2022
969
0.230
 Why?
Humans
43
2025
138102
0.230
 Why?
Lupus Nephritis
1
2025
65
0.230
 Why?
Class I Phosphatidylinositol 3-Kinases
1
2025
97
0.230
 Why?
Drug Resistance, Neoplasm
3
2024
796
0.230
 Why?
Lung Neoplasms
3
2024
2571
0.230
 Why?
Models, Biological
2
2021
1784
0.220
 Why?
Major Histocompatibility Complex
4
2021
230
0.220
 Why?
Lymphocytes, Tumor-Infiltrating
3
2021
206
0.220
 Why?
Disease Models, Animal
5
2024
4309
0.220
 Why?
Animals
24
2024
37151
0.220
 Why?
Tryptophan Oxygenase
1
2024
34
0.210
 Why?
Keratins
1
2024
171
0.210
 Why?
Bevacizumab
1
2024
140
0.210
 Why?
Cystadenocarcinoma, Serous
1
2024
78
0.210
 Why?
Signal-To-Noise Ratio
1
2023
64
0.210
 Why?
Interferons
2
2022
203
0.210
 Why?
Neoplasms, Experimental
2
2021
174
0.200
 Why?
Prognosis
5
2024
3982
0.200
 Why?
Artifacts
1
2023
129
0.200
 Why?
Dendritic Cells
4
2020
491
0.200
 Why?
Carcinoma, Non-Small-Cell Lung
2
2022
1110
0.200
 Why?
Fallopian Tubes
1
2022
32
0.200
 Why?
Ephrin-B2
2
2021
45
0.190
 Why?
Small Cell Lung Carcinoma
1
2024
115
0.190
 Why?
Fibrosis
2
2024
544
0.190
 Why?
Tretinoin
2
2023
122
0.180
 Why?
Neoplasms, Second Primary
1
2023
114
0.180
 Why?
Blood
1
2022
110
0.180
 Why?
Mycosis Fungoides
1
2021
60
0.180
 Why?
Flow Cytometry
5
2022
1194
0.180
 Why?
Gene Expression Profiling
3
2021
1755
0.180
 Why?
Precision Medicine
1
2025
420
0.170
 Why?
Synovial Membrane
1
2022
121
0.170
 Why?
ADAM10 Protein
1
2021
29
0.170
 Why?
Ovary
1
2022
223
0.170
 Why?
Seroconversion
1
2021
45
0.170
 Why?
Proteomics
3
2024
1109
0.170
 Why?
Middle Aged
11
2024
33509
0.170
 Why?
Amyloid Precursor Protein Secretases
1
2021
80
0.170
 Why?
Oligonucleotides, Antisense
1
2020
109
0.160
 Why?
Databases, Genetic
1
2021
241
0.160
 Why?
Eosinophilic Esophagitis
1
2024
325
0.160
 Why?
Immunity
1
2020
141
0.160
 Why?
Splenectomy
1
2020
62
0.160
 Why?
Macrophages
2
2024
1544
0.160
 Why?
Radiation Injuries
1
2021
147
0.160
 Why?
Diagnostic Imaging
1
2022
329
0.160
 Why?
Cell Adhesion
1
2020
465
0.150
 Why?
Survival Rate
2
2021
1912
0.150
 Why?
Case-Control Studies
3
2022
3569
0.150
 Why?
Adrenal Cortex Neoplasms
1
2020
60
0.150
 Why?
Receptor, EphB4
1
2019
33
0.150
 Why?
Neoplasm Invasiveness
1
2020
498
0.150
 Why?
Epithelial-Mesenchymal Transition
1
2021
211
0.150
 Why?
Adrenocortical Carcinoma
1
2020
63
0.150
 Why?
STAT3 Transcription Factor
1
2020
203
0.150
 Why?
T-Lymphocytes, Regulatory
3
2020
388
0.150
 Why?
Cell Communication
1
2020
315
0.150
 Why?
Radiosurgery
1
2022
390
0.150
 Why?
Isoxazoles
1
2018
53
0.150
 Why?
Ipilimumab
1
2018
33
0.150
 Why?
Interferon-alpha
1
2019
201
0.140
 Why?
Multiple Sclerosis
1
2024
461
0.140
 Why?
Autoantigens
1
2021
423
0.140
 Why?
Biomarkers, Tumor
2
2022
1235
0.140
 Why?
Mice, Transgenic
3
2024
2166
0.140
 Why?
Metabolome
1
2021
351
0.140
 Why?
Immunophenotyping
3
2017
324
0.140
 Why?
Antigens, CD19
1
2018
123
0.140
 Why?
Papillomavirus Infections
1
2022
379
0.140
 Why?
Lymphoma, Non-Hodgkin
1
2018
86
0.140
 Why?
Colonic Neoplasms
2
2012
253
0.140
 Why?
Drug Discovery
1
2018
146
0.140
 Why?
Head and Neck Neoplasms
1
2022
554
0.130
 Why?
Combined Modality Therapy
1
2020
1234
0.130
 Why?
Histone Deacetylase Inhibitors
1
2019
208
0.130
 Why?
Oxidation-Reduction
1
2020
1075
0.130
 Why?
Problem-Based Learning
1
2017
92
0.130
 Why?
Spodoptera
2
2021
40
0.130
 Why?
Students, Pharmacy
1
2017
100
0.120
 Why?
Adult
8
2024
38063
0.120
 Why?
Adipose Tissue
1
2020
645
0.120
 Why?
Cell Count
1
2017
318
0.120
 Why?
Triple Negative Breast Neoplasms
1
2019
203
0.120
 Why?
Algorithms
1
2023
1711
0.120
 Why?
Signal Transduction
4
2024
5068
0.120
 Why?
Cytotoxicity, Immunologic
2
2020
225
0.120
 Why?
Multiple Myeloma
1
2018
263
0.120
 Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2018
289
0.110
 Why?
Neoplasm Recurrence, Local
1
2021
1052
0.110
 Why?
Immunotherapy, Adoptive
1
2018
330
0.110
 Why?
Perception
1
2017
366
0.110
 Why?
Tumor Cells, Cultured
3
2021
946
0.110
 Why?
Membrane Proteins
1
2021
1154
0.110
 Why?
Liver Neoplasms
1
2020
759
0.110
 Why?
Aged
6
2024
23995
0.110
 Why?
Skin Neoplasms
1
2021
850
0.110
 Why?
Mice, Nude
3
2020
690
0.100
 Why?
Blood Cell Count
1
2013
54
0.100
 Why?
Arthritis, Rheumatoid
1
2022
1157
0.100
 Why?
Lipopolysaccharide Receptors
1
2013
89
0.100
 Why?
Prostatic Neoplasms
1
2020
1055
0.100
 Why?
Young Adult
3
2021
13329
0.100
 Why?
Down Syndrome
1
2019
486
0.100
 Why?
Immunohistochemistry
3
2022
1718
0.100
 Why?
Interferon-gamma
2
2021
788
0.100
 Why?
Apoptosis
4
2024
2555
0.090
 Why?
Male
11
2024
67984
0.090
 Why?
Suppressor Factors, Immunologic
1
2011
4
0.090
 Why?
Disease Progression
2
2024
2730
0.090
 Why?
Epitopes, T-Lymphocyte
1
2012
185
0.090
 Why?
Cells, Cultured
2
2017
4160
0.090
 Why?
B7-H1 Antigen
2
2024
216
0.090
 Why?
Datasets as Topic
2
2022
124
0.090
 Why?
Follow-Up Studies
1
2020
5144
0.090
 Why?
Curriculum
1
2017
1003
0.080
 Why?
Transcription Factors
1
2018
1709
0.080
 Why?
Neoplasm Proteins
1
2013
429
0.080
 Why?
Immunodominant Epitopes
1
2010
27
0.080
 Why?
Biomarkers
4
2024
4111
0.080
 Why?
Neoplasm Staging
1
2013
1371
0.080
 Why?
Genes, MHC Class I
1
2009
36
0.080
 Why?
Genetic Engineering
1
2009
93
0.070
 Why?
Complement System Proteins
2
2022
321
0.070
 Why?
Histocompatibility Antigens Class I
1
2010
203
0.070
 Why?
Cell Survival
2
2024
1130
0.070
 Why?
Histocompatibility Antigen H-2D
1
2008
21
0.070
 Why?
Cross-Priming
1
2008
16
0.070
 Why?
CD11c Antigen
1
2008
41
0.070
 Why?
Adjuvants, Immunologic
1
2009
238
0.070
 Why?
Molecular Targeted Therapy
2
2020
407
0.060
 Why?
RNA, Messenger
3
2024
2799
0.060
 Why?
Cell Culture Techniques
1
2009
363
0.060
 Why?
Aged, 80 and over
2
2020
7638
0.060
 Why?
Nephrocalcinosis
1
2025
13
0.060
 Why?
Immune Tolerance
1
2008
366
0.060
 Why?
Gene Expression
2
2022
1487
0.060
 Why?
Adolescent
2
2025
21637
0.060
 Why?
Ligands
2
2022
666
0.060
 Why?
Cancer-Associated Fibroblasts
1
2024
19
0.050
 Why?
Neuroendocrine Cells
1
2024
32
0.050
 Why?
Histocompatibility Antigens
1
2024
106
0.050
 Why?
Cell Line
1
2010
2865
0.050
 Why?
Microsatellite Repeats
1
2024
164
0.050
 Why?
Cell Differentiation
1
2011
1999
0.050
 Why?
Neoplasm Grading
1
2024
306
0.050
 Why?
Kynurenine
1
2024
114
0.050
 Why?
Imidazoles
1
2024
236
0.050
 Why?
Neuroendocrine Tumors
1
2024
108
0.050
 Why?
Mice, Inbred C57BL
3
2021
5769
0.050
 Why?
Tryptophan
1
2024
183
0.050
 Why?
Sf9 Cells
1
2021
10
0.040
 Why?
Tissue Distribution
1
2022
320
0.040
 Why?
CD47 Antigen
1
2021
38
0.040
 Why?
Autophagy
1
2024
286
0.040
 Why?
Lymphocytes
2
2020
392
0.040
 Why?
Hypoalbuminemia
1
2021
30
0.040
 Why?
Access to Information
1
2021
49
0.040
 Why?
Carcinogenesis
1
2022
216
0.040
 Why?
Ranolazine
1
2020
25
0.040
 Why?
Cell- and Tissue-Based Therapy
1
2021
82
0.040
 Why?
Animals, Genetically Modified
1
2002
244
0.040
 Why?
Cluster Analysis
1
2022
515
0.040
 Why?
Seroepidemiologic Studies
1
2021
163
0.040
 Why?
Enzyme Inhibitors
1
2024
847
0.040
 Why?
Data Mining
1
2021
116
0.040
 Why?
Receptors, CCR
1
2020
7
0.040
 Why?
Cytokines
3
2018
2079
0.040
 Why?
Platelet Count
1
2020
86
0.040
 Why?
RNA, Viral
1
2024
688
0.040
 Why?
Basophils
1
2020
72
0.040
 Why?
Hematopoiesis
1
2021
193
0.040
 Why?
Lymphocyte Subsets
1
2020
87
0.040
 Why?
Interleukin-6
1
2024
786
0.040
 Why?
Tumor Burden
1
2020
306
0.040
 Why?
Autoimmunity
1
2025
899
0.040
 Why?
Leukocyte Count
1
2020
320
0.040
 Why?
Swine
1
2002
796
0.040
 Why?
Mutation
1
2010
3994
0.040
 Why?
Pancreaticoduodenectomy
1
2020
122
0.040
 Why?
Postoperative Period
1
2020
348
0.040
 Why?
Biological Availability
1
2018
134
0.040
 Why?
Automation
1
2018
95
0.040
 Why?
Immunoglobulin G
1
2003
901
0.040
 Why?
Killer Cells, Natural
1
2021
451
0.040
 Why?
Gene Knockdown Techniques
1
2019
329
0.040
 Why?
Gene Expression Regulation, Neoplastic
1
2024
1388
0.040
 Why?
Radiotherapy
1
2019
206
0.040
 Why?
Complement Activation
1
2021
407
0.030
 Why?
Inpatients
1
2022
498
0.030
 Why?
Aging
1
2008
1859
0.030
 Why?
Structure-Activity Relationship
1
2018
568
0.030
 Why?
Kidney
1
2025
1475
0.030
 Why?
Molecular Structure
1
2018
495
0.030
 Why?
B-Lymphocytes
1
2003
849
0.030
 Why?
Lipid Metabolism
1
2020
523
0.030
 Why?
Homeostasis
1
2021
618
0.030
 Why?
Drug Delivery Systems
1
2020
357
0.030
 Why?
Protein Domains
1
2018
289
0.030
 Why?
Cell Movement
1
2021
971
0.030
 Why?
Administration, Oral
1
2018
786
0.030
 Why?
Comorbidity
1
2021
1638
0.030
 Why?
Metabolomics
1
2021
686
0.030
 Why?
Education, Pharmacy
1
2017
127
0.030
 Why?
Educational Measurement
1
2017
290
0.030
 Why?
Dose-Response Relationship, Drug
1
2018
2022
0.030
 Why?
Severity of Illness Index
1
2022
2838
0.030
 Why?
Program Evaluation
1
2017
912
0.020
 Why?
Neutrophils
1
2019
1270
0.020
 Why?
Retrospective Studies
2
2021
15750
0.020
 Why?
Cross Reactions
1
2012
130
0.020
 Why?
Antineoplastic Agents
1
2024
2125
0.020
 Why?
Indoleamine-Pyrrole 2,3,-Dioxygenase
1
2011
57
0.020
 Why?
Culture Media, Conditioned
1
2011
112
0.020
 Why?
Hospitalization
1
2021
2195
0.020
 Why?
Endocytosis
1
2011
175
0.020
 Why?
Enzyme-Linked Immunosorbent Assay
1
2012
854
0.020
 Why?
Universities
1
2013
442
0.020
 Why?
Treatment Outcome
1
2024
10832
0.020
 Why?
In Vitro Techniques
1
2011
1088
0.020
 Why?
Prospective Studies
1
2021
7603
0.020
 Why?
Enterotoxins
1
2006
88
0.020
 Why?
T-Lymphocytes, Cytotoxic
1
2006
174
0.020
 Why?
Drug Design
1
2006
165
0.010
 Why?
DNA Primers
1
2006
508
0.010
 Why?
Antigen Presentation
1
2006
220
0.010
 Why?
Blood Cells
1
2003
39
0.010
 Why?
CD40 Ligand
1
2003
41
0.010
 Why?
Colorado
1
2013
4553
0.010
 Why?
Coculture Techniques
1
2003
240
0.010
 Why?
Amino Acid Sequence
1
2006
2159
0.010
 Why?
Child
1
2021
21990
0.010
 Why?
Antibody Formation
1
2003
298
0.010
 Why?
Molecular Sequence Data
1
2006
2925
0.010
 Why?
Immunoglobulins
1
2002
169
0.010
 Why?
Organ Size
1
2002
473
0.010
 Why?
Mice, Knockout
1
2008
3014
0.010
 Why?
Cattle
1
2003
987
0.010
 Why?
Echocardiography
1
2002
645
0.010
 Why?
Birth Weight
1
2002
511
0.010
 Why?
Placenta
1
2002
752
0.010
 Why?
Phenotype
1
2002
3158
0.010
 Why?
Jordan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (299) concept(s)
_
Co-Authors Expand Description
See all (133) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)